Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride
NCT07508501Phase 1Completed
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Feb 2023
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ammoxetine (2 arms), sponsored by CSPC ZhongQi Pharmaceutical Technology. Primary endpoint: Pharmacokinetic parameters up to 48 hours. Started Feb 2023; status: completed.
02
Drugs
ammoxetine
Beyond the preview
Go deeper on NCT07508501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07508501.